October 7th, 2013
Hiroaki Shimokawa discusses his research group’s JACC study, in which they developed a comprehensive clinical risk score for VSA patients.
November 5th, 2012
An evening epidemiology session highlights the value of AHA.12, as a fellow garners multiple insights from a series of speakers.
March 12th, 2012
This week’s topics include stem cells for the heart, BP in both arms and vascular disease, and how patients and caregivers interpret prognostic information.
April 12th, 2011
Two papers presented at the World Congress of Nephrology and simultaneously published online in JAMA raise hope for better tools to calculate the risk for developing kidney failure, but the techniques are not yet ready for clinical use, according to an accompanying editorial. In the first study, Carmen Peralta and colleagues evaluated a triple-marker strategy combining […]